These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3893944)

  • 1. [Regulation of receptor sensitivity and psychiatry].
    Cai N
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Apr; 18(2):124-7. PubMed ID: 3893944
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?
    Crow TJ; Cross AJ; Johnstone EC; Owen F; Owens DG; Waddington JL
    J Clin Psychopharmacol; 1982 Oct; 2(5):336-40. PubMed ID: 7130435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia.
    Bermanzohn PC; Siris SG
    Compr Psychiatry; 1992; 33(4):221-32. PubMed ID: 1353715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia with Tourette-like syndrome.
    Seeman MV; Patel J; Pyke J
    J Clin Psychiatry; 1981 Sep; 42(9):357-8. PubMed ID: 6944306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor maturation in pathogenesis and treatment of Tourette syndrome.
    Friedhoff AJ
    Adv Neurol; 1982; 35():133-40. PubMed ID: 6959485
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychopathological and cognitive correlates of tardive dyskinesia in schizophrenia and other disorders treated with neuroleptic drugs.
    Waddington JL
    Adv Neurol; 1995; 65():211-29. PubMed ID: 7872142
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine receptors and locomotor responses: molecular aspects.
    Sealfon SC
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S12-9; discussion S19-21. PubMed ID: 10762128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ; Tarsy D
    Adv Biochem Psychopharmacol; 1980; 24():451-5. PubMed ID: 6105793
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Psychopharmacol Bull; 1981 Jan; 17(1):49-50. PubMed ID: 7232658
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical implications of receptor sensitivity modification.
    Friedhoff AJ; Miller JC
    Annu Rev Neurosci; 1983; 6():121-48. PubMed ID: 6573153
    [No Abstract]   [Full Text] [Related]  

  • 12. Up and down regulation: clinical significance of nervous system receptor-drug interactions.
    Kurlan R; Shoulson I
    Clin Neuropharmacol; 1982 Dec; 5(4):345-50. PubMed ID: 6130837
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced movement disorders.
    Gershanik OS
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):369-76. PubMed ID: 8099509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosomatic aspects of movement disorders.
    Cummings JL
    Adv Psychosom Med; 1985; 13():111-32. PubMed ID: 2931005
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine, depression and antidepressants.
    Dailly E; Chenu F; Renard CE; Bourin M
    Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptics and serotonin].
    Hery F; Hamon M
    Encephale; 1993; 19(5):525-32. PubMed ID: 7905821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M; Friedhoff AJ; Diamond F
    Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
    [No Abstract]   [Full Text] [Related]  

  • 18. Tardive dyskinesia with Tourette-like syndrome.
    Rebal RF
    J Clin Psychiatry; 1982 May; 43(5):215. PubMed ID: 6122679
    [No Abstract]   [Full Text] [Related]  

  • 19. Schizophrenia and DA-hypothesis: pathological and therapeutic aspects. 9th annual meeting of the Belgian College of Neuropsychopharmacological and Biological Psychiatry. Louvain-en-Woluwe, 21 November 1986. Proceedings.
    Acta Psychiatr Belg; 1987; 87(5):521-617. PubMed ID: 3451673
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathophysiology and therapy of L-Dopa-induced dyskinesia].
    Hadj Tahar A; Bézard E; Grondin R; Gross CE; Bédard PJ
    Rev Neurol (Paris); 2003 Dec; 159(12):1125-42. PubMed ID: 14978413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.